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Intravenous (i.v.) administration of phagocytosable chitin particles (1 to 10 mm) in C57BL/6 mice and SCID
mice primed alveolar macrophages (Mf) within 3 days to yield up to a 50-fold increase in their oxidative burst
when elicited in vitro with phorbol myristate acetate (PMA). C57BL/6 mice pretreated with monoclonal
antibodies (MAbs) against mouse gamma interferon (IFN-g) or NK1.1 showed a markedly decreased level of
alveolar Mf priming following injection of chitin particles. To confirm IFN-g production in vitro, spleen cells
isolated from normal C57BL/6 mice and SCID mice were cultured with chitin particles. Significant IFN-g
production was observed following stimulation with chitin but not with chitosan or latex beads. When spleen
cells were treated with anti-NK1.1 MAb, IFN-g production was significantly inhibited. Another set of exper-
iments showed that when C57BL/6 mice were pretreated i.v. with a small dose IFN-g, a higher level of priming
was induced with not only phagocytosable chitin particles but also phagocytosable chitosan and even latex
beads. Likewise, the spleen cell cultures preconditioned with IFN-g provided an up-regulation of IFN-g
production by these phagocytosable particles. Taken together, the in vivo and in vitro results suggest that (i)
the alveolar Mf priming mechanism is due, at least in part, to direct activation of Mf by IFN-g, which is
produced by NK1.11 CD42 cells; (ii) IFN-g would have an autocrine-like effect on Mf and make them more
responsive to particle priming; and (iii) phagocytosis of particulates, probably by a postmembrane event such
as interiorization, appears to be important for the up-regulation of alveolar Mf priming and IFN-g produc-
tion.
It is well established that endogenous gamma interferon
(IFN-g) produced by natural killer (NK) cells and activated T
cells is an essential cytokine involved in protective cell-medi-
ated immunity (CMI) against facultative intracellular bacteria,
including Listeria monocytogenes and Mycobacterium tubercu-
losis (7, 9, 13), fungi (19), and parasites (31). IFN-g-primed
macrophages (Mf) are known to become microbicidal by mas-
sively releasing toxic agents including reactive oxygen interme-
diates (ROI) and reactive nitrogen intermediates. It is also
known that IFN-g up-modulates the early development of cell-
mediated immune (Th1) responses and down-modulates hu-
moral immune (Th2) responses in these infectious models
(31).
Myrvik et al. have observed recently that the intravenous
(i.v.) administration of phagocytosable-size particles in New
Zealand White rabbits primes alveolar Mf within 1 to 3 days
to yield up to a 100-fold increase in their oxidative burst in
vitro when elicited with phorbol myristate acetate (PMA) or
opsonized zymosan (21). In this up-regulation, it appears that
bacteria (heat-killed [HK] Mycobacterium bovis BCG) and mi-
crobial particulate components (zymosan) are more effective
than phagocytosable-size polystyrene latex beads (21). The
magnitude of the elicited oxidative responses of alveolar Mf
primed nonspecifically with HK BCG was comparable to the
maximum priming achieved (up to 100-fold) 2 to 3 weeks after
specific immunization with HK BCG in oil (8, 14).
Alveolar Mf phagocytosing these particles in vitro, however,
do not express such up-regulation of superoxide anion release,
which suggests that additional cell populations or immuno-
regulatory mediators are involved in the in vivo particle-prim-
ing response (21). In this regard, current publications (17, 31,
32, 40) indicate that the initial phagocytosis of bacteria such as
L. monocytogenes results in the production of mediators such
as interleukin-12 (IL-12) and tumor necrosis factor alpha
(TNF-a) which induce the maturation of NK and Th1 cells and
their production of IFN-g. This CMI response appears to be
highly regulated by various additional immunoregulatory me-
diators, including IL-4, IL-10, transforming growth factor
(TGF-b), and prostaglandin E2 (PGE2).
Based on this information, we hypothesized that (i) appro-
priate biodegradable and nontoxic particles induce local Mf to
become bactericidal, which could be beneficial in the prophy-
laxis and treatment of infection; (ii) the selected particles ad-
ministered initiate CMI responses along with IFN-g produc-
tion, which primes Mf; and (iii) endogenous IFN-g, as an
endogenous adjuvant, further amplifies the particle-induced
MØ priming.
Chitin and chitosan, polymers of N-acetyl-D-glucosamine
and deacetylated glucosamine, respectively, are essential com-
ponents of fungal cell walls and have been the targets of anti-
fungal drugs (11, 22). Chitin and chitosan are similar in struc-
ture to cellulose and are the second most abundant
polysaccharides in nature, comprising the horny substance in
the exoskeletons of crabs, shrimp, and insects as well as fungi.
Because some of their derivatives are proved to be nontoxic,
biodegradable, and biocompatible, prostheses (artificial skin
[matrix], contact lens, and surgical stitch) produced from the
chitin derivatives have been developed and widely used in
medical practice. In addition, a series of studies by Azuma and
colleagues suggest that some chitin/chitosan derivatives are
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able to up-regulate Mf functions (measured by TNF, IL-1, and
colony-stimulating factor production) and induce immunologic
adjuvant effects (2, 24–26). This information has led us to test
the effects of chitin/chitosan particles (mimetic microbes) on
alveolar Mf activation and to further determine the mecha-
nisms of the particle-induced Mf priming.
The specific aims of this study were to (i) establish mouse
models for alveolar Mf priming induced by phagocytosable-
size chitin/chitosan particles, using C57BL/6 and SCID mice;
(ii) determine the roles of NK cells and endogenous IFN-g in
the chitin/chitosan-induced alveolar Mf priming in C57BL/6
mice, using selective inactivation of IFN-g and depletion of
NK1.11 cells by the administration of monoclonal antibodies
(MAbs) specific for IFN-g and NK1.1, respectively; (iii) exam-
ine chitin/chitosan particle-induced IFN-g production in vitro
by selected spleen cell populations; and (iv) assess the effects of
exogenous IFN-g on the in vivo chitin/chitosan-induced alve-
olar Mf priming response and on the in vitro pattern of IFN-g
production.
MATERIALS AND METHODS
Mice. Nonpregnant, 7- to 9-week-old female C57BL/6 and CB-17/IRC (SCID)
mice (both from Charles River Laboratories, Wilmington, Mass.) were main-
tained in barrier-filtered cages and fed Purina Laboratory Chow and tap water ad
libitum.
Preparations of chitin/chitosan particles. Chitin powders (Sigma Chemical
Co., St. Louis, Mo.) and chitosan powders (Kyowa Technos, Chiba, Japan) were
suspended at 10 mg/ml in saline and sonicated at 25% output power two times
for 5 min each with a Branson sonicator (Sonifier 450; Branson Ultrasonics,
Danbury, Conn.). Following a light centrifugation (50 3 g, 10 min), the super-
natants mainly contained small particles (1 to 10 mm in diameter) which were
removed, filtered through a 400/2,800 stainless steel mesh, and further centri-
fuged to collect the particles at 1,400 3 g for 10 min. One milligram of chitin/
chitosan particles (1 to 10 mm) contained 2 3 108 to 3 3 108 particles (data not
shown). On the other hand, the (50 3 g)-centrifuged pellets containing large
particles (50 to 100 mm) were resuspended in saline, filtered through a 200/600
stainless steel mesh, and centrifuged at 1,400 3 g for 10 min to obtain the large
particles. Chitin oligosaccharides and chitosan oligosaccharides were kindly pro-
vided by Aihara, Kyowa Technos. Particle sizes and size distribution were flow
cytometrically determined by using several sizes of latex bead controls (1.1, 10.0,
and 47.8 mm in diameter; Polysciences, Warrington, Pa.). Figure 1 shows chitin
particles with typical size distributions of the particles.
In vivo neutralization of IFN-g. Endogenously produced IFN-g was neutral-
ized by injecting mice intraperitoneally (i.p.) with 2 3 105 neutralizing units of
anti-IFN-g MAb R4-6A2 (specific activity, 2 3 105 neutralizing units per mg of
immunoglobulin G [IgG]; a generous gift from E. A. Havell, Trudeau Institute,
Saranac Lake, N.Y.) 1 day before the chitin injection. An equivalent amount of
normal rat IgG (Sigma) was used to control for the nonspecific effects of injecting
foreign immunoglobulin.
In vivo NK1.11 cell depletion. In vivo depletion of NK1.11 cells was achieved
1 day before chitin particle administration by i.p. injection of 5 mg of anti-NK1.1
(IgG2a; clone PK 136 from the American Type Culture Collection [ATCC],
Rockville, Md.) which was purified from mouse ascites fluid by ammonium
sulfate precipitation with a 50% saturated solution. The extent of NK1.11 cell
depletion was determined by flow cytometry as described below. Control mice
received saline.
Alveolar Mf and spleen cells. Alveolar Mf were obtained by repeated pul-
monary lavage with a total 5 ml of sterile Hanks’ balanced salt solution (pH 7.2).
Mf enrichment was done by the plastic adherence method (378C, 1 h) in the
presence of 10% heat-inactivated fetal bovine serum (FBS). Spleens were gently
minced with scissors and filtered through a stainless steel sieve. Removal of
adherent Mf from spleen cell suspensions was done by passage through a
Sephadex G-10 column (33). Plastic-adherent spleen Mf were prepared as
described previously (33). In certain experiments, NK1.11 cells and CD41 cells
in the spleen cells were eliminated with MAbs against NK1.1 (clone PK 136;
ATCC) and CD4 (clone GK 1.5; ATCC), respectively, followed by treatment
with rabbit serum (1:10; Sigma) as a source of complement. The effect of the
treatment was confirmed by indirect immunofluorescence staining with the
MAbs against F4/80, NK1.1, and CD4 as described below.
Cell enumeration. Plasma membranes of spleen cells and alveolar Mf which
were freshly isolated and cultured were lysed with Zapoglobin (Coulter Diag-
nostics, Hialeah, Fla.). Nuclei were counted with an electronic particle counter
(Coulter Counter model D2). Viable cell counts were performed by trypan blue
dye exclusion. Differential cell counts were made on cytocentrifuged prepara-
tions and stained with May-Gruenwald-Giemsa stain.
Flow cytometric cell characterization. The expression of surface antigens on
the Mf, T cells, and NK cells was determined by indirect immunofluorescence in
the presence of 5% heat-inactivated newborn calf serum (GIBCO, Grand Island,
N.Y.), pH 7.2 (34). Serum-free culture supernatants containing MAbs against
F4/80, NK1.1, and CD4 were prepared from hybridoma cell lines F4/80, PK 136,
and GK 1.5, respectively (all from ATCC). MAbs in the culture supernatants
were purified by an ammonium sulfate precipitation with a 50% saturated solu-
tion. Fluorescein isothiocyanate-conjugated donkey anti-mouse IgG and donkey
anti-rat IgG (both from Jackson ImmunoResearch, West Grove, Pa.) were used
as secondary antibodies for indirect immunofluorescence. Fluorescence of 104
stained cells was quantitated with a FACScan flow cytometer using the FACScan
research program (Becton Dickinson, Mountain View, Calif.). All tested cells as
defined by forward and sideward scatter pattern were gated; only debris was
excluded from analysis. Cells stained with the second antibody alone were used
as negative controls in all experiments.
Protocol for in vivo priming of mice. To prime alveolar MØ in vivo, mice were
injected i.v. with 0.1 or 1 mg of chitin/chitosan particles suspended in 0.2 ml of
endotoxin-free saline. The alveolar Mf were harvested 1 to 7 days postinjection.
In comparison controls, mice received i.v. 1 mg of HK Corynebacterium parvum
vaccine (33) or 1.1-mm latex beads.
Superoxide anion release assay. Superoxide dismutase (SOD)-inhibitable su-
peroxide anion levels released by alveolar Mf were measured by a cytochrome
c reduction assay. Adherent Mf were placed in a 24-well plate (Corning, Corn-
ing, N.Y.) with HEPES-bicarbonate buffer containing 50 mM ferricytochrome c
(Sigma). Mf were incubated at 378C for 1 h in the presence or absence of PMA
(1026 M). SOD (700 U/ml; Sigma) was also added as a negative control. The
amount of reduced ferricytochrome c was measured by using a molecular ex-
tinction coefficient of 21.1 mM21 cm21 from the change in absorbance at 550 nm
against a cell-free blank (3, 18). Superoxide formation was expressed as nano-
moles/106 cells.
Production of IFN-g by spleen cell cultures stimulated with chitin. Spleen
cells isolated from normal C57BL/6 and SCID mice were resuspended (2 3 106
cells/ml) in RPMI 1640 plus 10% heat-inactivated FBS and incubated with
chitin/chitosan particles at various doses at 378C. After 24 h of incubation, the
culture supernatants were harvested, filtered (0.22-mm-pore-size filter), and
stored at 2808C for later assays for IFN-g. In some experiments, chitin particle-
stimulated spleen cell cultures were further treated with cytokines (recombinant
mouse IFN-g [Sigma], recombinant mouse IL-4 [Pepro Tech, Rocky Hill, N.J.],
recombinant mouse IL-10 [Pepro Tech], and natural human TGF-b1 [Genzyme,
FIG. 1. Determination of size distribution of chitin particles. The size distri-
butions of two different preparations of chitin particles (1- to 10-mm [phagocy-
tosable-size] [A] and 50- to 100-mm [nonphagocytosable size] [B] particles) as
described in Materials and Methods were determined by a FACScan cell sorter.
Alveolar Mf (AM) and latex beads at diameters of 1.1, 10.0, and 47.8 mm were
used as comparison controls. The x and y axes indicate particle sizes defined by
forward scatter and particle numbers, respectively.
VOL. 65, 1997 CHITIN PARTICLES PRIMING FOR MICROBICIDAL MACROPHAGES 1735
Cambridge, Mass.]), PGE2 (Sigma), and antibodies (rat anti-mouse IL-12 [clone
17.8; Genzyme] and polyclonal rabbit anti-mouse TNF-a [Genzyme]). To re-
move possibly contaminated endotoxin, all tissue culture media and soluble
reagents were passed through a polymyxin B column (Sigma), followed by con-
current filtration and sterilization through 0.22-mm-pore-size Zetapore filters
(Cuno, Meriden, Conn.) manufactured for this purpose (34, 35).
IFN-g assay. The levels of mouse IFN-g in the spleen cell cultures were
measured with specific two-site enzyme-linked immunosorbent assay (ELISA)
using monoclonal anti-mouse/rat IFN-g (clone DB-1; Biosource, Camarillo, Cal-
if.) as a capture antibody and rabbit polyclonal anti-mouse IFN-g (Biosource) as
a detector antibody. Briefly, Immunlon II plates (Nunc) were coated with the
MAb overnight. The following day, the plates were blocked with 5% heat-
inactivated newborn calf serum for 1 h and then washed. Samples from in vitro
spleen cell cultures were added to the wells. The plates were incubated overnight
at 48C and then washed four times with 0.05% Tween-Tris buffer (pH 7.2). The
secondary antibodies were added for 1 h, followed by extensive washing. Finally,
horseradish peroxidase conjugates were added for 30 min and washed, and the
peroxide substrates were mixed with o-phenylenediamine dihydrochloride (Sig-
ma). After the reaction was stopped with 3 N HCl, the plates were read spec-
trophotometrically at 492 nm. IFN-g levels were quantitated based on a standard
curve obtained by using recombinant mouse IFN-g (Sigma).
Statistics. Difference between mean values were analyzed by Student’s t test.
P values of less than 0.05 were considered statistically significant.
RESULTS
Enhancement of superoxide anion release by alveolar Mf
following i.v. administration of chitin/chitosan particles. A
1-mg dose of chitin particles (1 to 10 mm [Fig. 1], 2 3 108 to
33 108 particles) was administered i.v. to C57BL/6 mice. After
selected periods, alveolar lavage cells were collected and incu-
bated in the presence of 10% FBS for 1 h. The adherent cells
(.90% of Mf determined morphologically [data not shown])
were isolated. ROI release by PMA-elicited alveolar Mf was
detected as described in Materials and Methods. As shown in
Fig. 2, normal alveolar Mf generated superoxide anion at a
level less than 0.2 nmol/106 cells/h when elicited with PMA. In
contrast, the ROI levels were greatly enhanced 1 to 3 days after
the injection of chitin particles; the levels returned to normal
by day 7. SOD at 700 U/ml completely inhibited the ROI
release by alveolar Mf (Fig. 2).
As shown in Fig. 3, SCID mice receiving chitin particles also
showed a massive ROI release by alveolar Mf in vitro equal to
or greater than that of C57BL/6 mice. These data suggest that
neither T nor B lymphocytes appear to be essential for parti-
cle-induced Mf activation.
In contrast, chitosan particles (1 to 10 mm) at the same dose
(1 mg/mouse) showed significantly less capacity to prime alve-
olar Mf to release superoxide anion (Table 1). There was no
effect of chitin oligosaccharides and chitosan oligosaccharides
(Table 1).
Effect of treatments with anti-NK1.1 or anti-IFN-g in
C57BL/6 mice. To further assess the obligatory role of NK cells
for Mf priming, C57BL/6 mice were pretreated with anti-
NK1.1 MAb i.p. 1 day before chitin particle injection. The
MAb treatment resulted in a significant reduction of splenic
NK1.11 cells but not CD41 cells detected by flow cytometric
monitoring (Fig. 4) as well as the priming effect on alveolar Mf
as determined by PMA-elicited ROI release (Fig. 5).
It has been reported that neutralization of IFN-g in mice
FIG. 2. Kinetics of superoxide anion release by alveolar Mf in C57BL/6 mice
given chitin particles i.v. C57BL/6 mice (three/group) received 1 mg of chitin
particles (1 to 10 mm) i.v. After the indicated days, alveolar Mf in each mouse
were assayed in vitro for PMA-elicited superoxide anion release in the presence
(open bars) or absence (solid bars) of 700 U of SOD. Results are expressed as
means6 SD (n5 3). p, P, 0.05 compared with groups without SOD treatment.
FIG. 3. Superoxide anion release by alveolar Mf in C57BL/6 mice and SCID
mice given chitin particles i.v. at different doses. Groups of C57BL/6 mice (open
bars) and SCID mice (solid bars) received chitin particles (1 to 10 mm) at 0
(saline), 0.1, and 1 mg per mouse (three mice/group). After 3 days, alveolar MØ
in each mouse were assayed in vitro for PMA-elicited superoxide anion release.
Results are expressed as means 6 SD (n 5 3).
TABLE 1. Alveolar Mf priming by i.v. injection of chitin particles
at selected sizes in C57BL/6 micea
Particle Size Dose (mg) O22 (nmol/106 cells/h)
Expt 1
Saline 0.5
Chitin 1–10 mm 1 20.3*
Chitosan 1–10 mm 1 7.2*
Chitin Oligosaccharide 1 0.5
Chitosan Oligosaccharide 1 0.5
Expt 2
Saline 0.5
Chitin 1–10 mm 1 17.9*
HK C. parvum 1 24.5*
Latex beads 1.1 mm 1 0.7
a Groups of 3 C57BL/6 mice were injected i.v. with the particle preparations
indicated. Bronchoalveolar lavage cells were collected day 3. Superoxide anion
released by alveolar Mf was determined as described in Materials and Methods.
Results are expressed as means (n 5 3). p, P , 0.05 compared with the control
(saline) group.
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infected with L. monocytogenes by using anti-murine IFN-g
MAbs causes a lethal exacerbation of a sublethal infection (12,
40). To determine whether endogenous IFN-g was produced
during the particle priming, we treated C57BL/6 mice with 2 3
105 neutralizing units of rat anti-IFN-g MAb 1 day before
inoculating chitin particles. Figure 5 shows that the treatments
with the MAb resulted in a significant reduction of the priming
effect on alveolar Mf, while there was little or no effect of
control IgG.
Figure 6 shows that when alveolar Mf isolated from normal
C57BL/6 mice were treated with exogenous IFN-g (10 and 100
U/ml) in vitro for 24 h, IFN-g primed alveolar Mf in a dose-
dependent manner.
Preadministration of IFN-g in C57BL/6 mice modulates
particle-induced alveolar Mf priming. To further assess the
role of IFN-g in particle-induced alveolar Mf priming, we
injected mouse recombinant IFN-g (10,000 U) i.v. in C57BL/6
mice 4 h before the particle priming with chitin and chitosan.
Although IFN-g alone at this dose did not prime alveolar Mf
at day 3, the additional injection of chitin particles (1 to 10 mm)
primed alveolar Mf to a level in which they released signifi-
cantly more ROI release when elicited by PMA in vitro (Table
2) compared to mice that did not receive an injection of IFN-g.
Surprisingly, chitosan particles and even 1.1-mm latex beads
also induced significant alveolar Mf priming in mice that were
treated with exogenous IFN-g (Table 2). Oligosaccharides of
chitin and chitosan, however, did not show any priming effects
(Table 2).
In vitro chitin/chitosan particle-induced IFN-g production
in spleen cell cultures. It has been reported that mouse spleen
cells incubated with HK bacteria (for example, L. monocyto-
genes, BCG, and C. parvum) produce IFN-g (16, 17, 39, 40).
FIG. 4. Splenic NK1.11 cells and CD41 cells in C57BL/6 mice treated with
anti-NK1.1 MAb. C57BL/6 mice were treated with anti-NK1.1 MAb (B and D)
or with saline (A and C) as described for Fig. 5, and NK1.11 cells (A and B) and
CD41 cells (C and D) in the spleen cells were determined cytometrically. The
histogram obtained by staining with either anti-NK1.1 or anti-CD4 was shown by
a solid line which was superimposed with a shaded background (NSB) obtained
by staining with the second antibody alone.
FIG. 5. In vivo priming of mouse alveolar Mf induced by i.v. injection of
chitin particles in C57BL/6 mice pretreated with MAbs against IFN-g or NK1.1.
C57BL/6 mice (three mice per group) were injected i.p. with anti-NK1.1 mouse
IgG at 5 mg (A) or anti-IFNg rat IgG at 1 mg (B) 1 day before i.v. injection of
chitin particles at 1 mg/mouse. Control mice in panels A and B received saline
and rat IgG (1 mg), respectively, before the chitin particle (1 to 10 mm) injection.
Three days after the particle injection, alveolar lavage Mf in each mouse were
assayed in vitro for superoxide anion release with PMA (1 mM) as the eliciting
agent. Results are expressed as means 6 SD (n 5 3). p, P , 0.05 compared with
the control (saline) or (rat Ig) group.
FIG. 6. In vitro alveolar Mf primed with IFN-g. Alveolar Mf isolated from
normal C57BL/6 mice were incubated with IFN-g at 0 (medium alone), 10, and
100 U/ml for 24 h at 378C. Superoxide anion levels released by the IFN-g-primed
Mf were measured in the presence (open bars) or absence (solid bars) of SOD
at 700 U/ml following PMA elicitation. Results are expressed as means 6 SD
(n 5 3). p, P , 0.05 compared with groups without SOD treatment.
TABLE 2. Effect of administration of IFN-g before the injection of
chitin/chitosan particles on the alveolar Mf priming in
C57BL/6 micea
Particle Size Dose(mg)
O22 (nmol/106 cells/h)
No treatment IFN-g treatment
Saline 0.5 0.5
Chitin 1–10 mm 1 14 20*
Chitosan 1–10 mm 1 4.3 14*
Chitin Oligosaccharide 1 0.5 0.5
Chitosan Oligosaccharide 1 0.5 0.5
Latex beads 1.1 mm 1 0.7 12*
a C57BL/6 female mice (three per group) were injected i.v. with recombinant
mouse IFN-g (10,000 U; Sigma) or saline (control) 4 h before i.v. injection of
chitin particles, chitosan particles, or 1.1-mm latex beads at 1 mg/mouse. Alveolar
lavage Mf in each mouse were assayed in vitro for superoxide anion release with
1 mM PMA as the eliciting agent. Results are expressed as means (n5 3). p, P,
0.05 compared with the control (no treatment) groups.
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Based on this information, we incubated normal spleen cells
isolated from C57BL/6 and SCID mice in the presence of
various forms of chitin and chitosan.
Our initial studies using C57BL/6 mouse spleen cells showed
that IFN-g production was detected (7 6 3 U/ml [mean 6
standard deviation {SD}, n 5 3]) 4 h after 1- to 10-mm chitin
particle stimulation (100 mg/ml), became maximum (64 6 10
U/ml) at 24 h, and declined slightly (49 6 8 U/ml) after 48 h
(data not shown). Table 3 shows that the chitin particles in-
duced significant amounts of IFN-g production 24 h after the
stimulation, at a level approximately 50% of the level induced
by HK C. parvum in spleen cells isolated from both the strains
of normal mice. Unlike HK C. parvum, either 1.1-mm or
47.8-mm latex beads as comparison controls did not induce
IFN-g production (Table 3). Neither the large chitin particles
(50 to 100 mm) nor chitin oligosaccharides induced IFN-g
production. Furthermore, it is notable that none of the chi-
tosan preparations used in this study induced detectable
amounts of IFN-g production in either C57BL/6 or SCID
mouse spleen cells.
IFN-g production by the C57BL/6 mouse spleen cells de-
pleted of NK1.11 cells or adherent cells. To determine the key
cell populations in the spleen cell cultures that were responsi-
ble for IFN-g production, several spleen cell subpopulations
were fractionated and incubated with chitin particles (1 to 10
mm). As shown in Table 4, neither nonadherent spleen cells
prepared by passing cell suspensions through Sephadex G-10
columns nor plastic-adherent spleen cells produced significant
amounts of IFN-g. When the two cell populations were mixed,
chitin particle-induced IFN-g production was restored (Table
4). F4/801 Mf in the nonadherent cell and adherent cell pop-
ulations amounted to 0.5 and 84%, respectively (data not
shown).
Furthermore, spleen cells depleted of NK1.11 cells showed
a significant reduction of chitin particle-induced IFN-g levels,
whereas the elimination of CD41 cells resulted in a slight
enhancement of IFN-g production (Table 4).
Effects of neutralizing antibodies against IL-12 and TNF-a
on chitin particle-induced IFN-g production. To test a role of
selected IFN-g-inducing cytokines (IL-12 and TNF-a) for
chitin particle-induced IFN-g production, spleen cell cultures
(C57BL/6 mice) stimulated with 1- to 10-mm chitin particles
were pretreated with neutralizing antibodies against IL-12
(bioactive IL-12p70) and TNF-a. As shown in Fig. 7, both
treatments resulted in significantly blocking IFN-g production,
suggesting that the two cytokines play obligatory roles in chitin
particle-induced IFN-g production.
Exogenous inflammatory mediators (IFN-g, IL-4, IL-10,
TGF-b1, and PGE2) modulate chitin particle-induced IFN-g
production in C57BL/6 mouse spleen cell cultures. To assess
the effect of exogenous IFN-g on particle-induced IFN-g pro-
duction, the spleen cells were preincubated with IFN-g at 100
U/ml for 12 h before particle stimulation. Table 5 showed that
phagocytosable-size particles (chitin, chitosan, latex beads, and
HK C. parvum) but not large (50- to 100-mm) particles (chitin,
chitosan, and latex beads) or oligosaccharides (chitin and chi-
tosan) further induced significantly higher levels of IFN-g in
the exogenous IFN-g-treated spleen cells than in control
FIG. 7. Effects of neutralizing antibodies against IL-12 and TNF-a on chitin
particle-induced IFN-g production. Spleen cells isolated from C57BL/6 mice
were incubated with 1- to 10-mm chitin particles at 100 mg/ml in the presence of
either rat anti-IL-12 (40 mg/ml; clone 17.8), polyclonal rabbit anti-mouse TNF-a
(40 mg/ml), or rat anti-IFN-g (40 mg/ml; clone R4-6A2, as a comparison control)
for 24 h at 378C. Control group had a mixture of rat immunoglobulin (40 mg/ml;
Sigma) and rabbit immunoglobulin (40 mg/ml; Sigma). The levels of IFN-g in the
culture supernatants were measured as described in Materials and Methods.
Results are expressed as means6 SD (n5 3). p and pp, P, 0.005 and P, 0.001,
respectively, compared with the immunoglobulin control group.
TABLE 3. IFN-g production by mouse spleen cells cultured with
chitin or chitosana
Particle Size Dose (mg/ml)
IFN-g (U/ml)
C57BL/6 SCID
Saline ,5 ,5
Chitin 1–10 mm 0.1 54* 65*
Chitosan 1–10 mm 0.1 ,5 ,5
Chitin 50–100 mm 0.1 ,5 8
Chitosan 50–100 mm 0.1 ,5 ,5
Chitin Oligosaccharide 0.1 ,5 ,5
Chitosan Oligosaccharide 0.1 ,5 ,5
HK C. parvum 0.1 110* 127*
Latex beads 1.1 mm 0.1 ,5 ,5
47.8 mm 0.1 ,5 ,5
a Spleen cells isolated from C57BL/6 mice or SCID mice were suspended in
RPMI 1640 plus 10% FBS (4 3 106 cells/ml) and incubated with the particles
indicated. After 24 h of incubation, the culture supernatants were filtered with a
0.22-mm-diameter filter, and IFN-g levels in the filtrates were measured by
ELISA. Results are expressed as means (n 5 3). p, P , 0.05 compared with the
control (saline) group.
TABLE 4. Effects of C57BL/6 mouse spleen cells depleted of NK
cells or CD41 cells on the production of IFN-ga
Treatment IFN-g(U/ml)
Spleen cells ........................................................................................ 78
Nonadherent spleen cells ................................................................. 7*
Adherent spleen cells ....................................................................... 8*
Nonadherent spleen cells 1 adherent cells................................... 85
Spleen cells treated with: ................................................................
Rabbit serum ................................................................................. 74
Anti-NK1.1 1 rabbit serum......................................................... 9**
Anti-CD4 1 rabbit serum............................................................ 83
a C57BL/6 mouse spleen cells, nonadherent spleen cells, adherent spleen cells,
and spleen cells pretreated with either anti-NK1.1 (PK 136) plus rabbit serum
(1:10 dilution; Sigma), anti-CD4 (GK 1.5) plus rabbit serum, or rabbit serum
alone were suspended in RPMI 1640 plus 10% FBS at 4 3 106 cells/ml and
incubated with chitin particles (1 to 10 mm) at 0.1 mg/ml for 24 h. In some
experiments, nonadherent spleen cells (23 106 cells/ml) and nonadherent spleen
cells (23 106 cells/ml) were mixed before chitin particle stimulation. The culture
supernatants were filtered, and IFN-g levels in the filtrates were measured by
ELISA. Data are presented as means (n5 3). Without chitin, IFN-g levels in the
six groups were,5 U/ml. p and pp, P, 0.05 compared with spleen cell group and
rabbit serum-treatment group, respectively.
1738 SHIBATA ET AL. INFECT. IMMUN.
spleen cells. In sharp contrast, the chitin particle-induced
IFN-g production was significantly inhibited by the presence of
selected inflammatory mediators (IL-4, IL-10, and TGF-b1,
and PGE2) (Table 6).
To determine whether chitin/chitosan preparations used in
this study induce such factors which could inhibit IFN-g pro-
duction, the culture supernatants of particle-induced spleen
cells were added to the chitin particle-induced spleen cell cul-
tures. As shown in Table 6, the supernatants which did not
contain IFN-g (Table 3) failed to inhibit IFN-g production.
Our data suggest that the failure of IFN-g production by chitin/
chitosan preparations other than 1- to 10-mm chitin particle
preparations is not due to the presence of factors which are
known to down-modulate IFN-g production. Our preliminary
study, in addition, indicated that there was no detectable level
of IL-4 (,20 pg/ml, determined by ELISA [Genzyme]) in any
particle-stimulated spleen cell cultures used in this study (data
not shown).
It is of special interest that control spleen cell cultures in-
cubated in the absence of chitin particles produced IFN-g
when costimulated with the culture supernatants of chitin par-
ticle-stimulated spleen cells (Table 6). These data suggest that,
in addition to IFN-g, chitin particles induce other factors,
including IL-12 and TNF-a, which augment IFN-g production.
DISCUSSION
When chitin/chitosan particles, structures with no mamma-
lian counterpart, are administered i.v. to mice, they become
bound to Mf plasma membrane mannose/fucose receptors
(19, 28, 38, 41) that mediate the interiorization of the chitin/
chitosan particles if they are in the phagocytosable range.
These particles are eventually degraded by lysozyme and
N-acetyl-b-D-glucosaminidase, which are present in the phago-
cytic Mf and sera in human and experimental animals (6, 15).
The present study clearly indicates that the i.v. injection of
C57BL/6 mice with phagocytosable chitin particles primes al-
veolar Mf within 3 days to give a large oxidative burst when
elicited in vitro with PMA. Phagocytosable chitosan also
primes alveolar Mf but at a significantly lower level of the
elicited oxidative response than the phagocytosable chitin. Sol-
uble chitin oligosaccharides and chitosan oligosaccharides, in
sharp contrast, are unable to prime alveolar Mf. The magni-
tude of the elicited oxidative responses of alveolar Mf primed
by i.v. injection of chitin particles is comparable to the maxi-
mum priming achieved by HK C. parvum. Our data strongly
suggest that initial phagocytosis of chitin particles or bacteria
but not latex beads is the key event for alveolar Mf priming.
Another important finding is that the mechanism for alveo-
lar Mf priming by the chitin particle involves, at least in part,
the production of endogenous IFN-g. We also found that a
comparable level of alveolar Mf priming is induced in SCID
mice receiving chitin particles i.v., indicating that neither T nor
B lymphocytes are required for the particle priming response
in this animal model. We also established that the administra-
tion of monoclonal anti-NK1.1 antibodies to C57BL/6 mice
caused depletion of their NK1.11 cells as well as the priming
response of alveolar Mf. It has been reported that the resis-
tance of mice to L. monocytogenes infection involves an early,
(1 to 2 days) nonspecific phase of resistance, mediated by
IFN-g produced by NK cells, which appears to be an essential
immune mechanism to eliminate bacteria in SCID mice as well
as in immunocompetent mice (12, 40). In our study, the injec-
tion of C57BL/6 mice and SCID mice with chitin particles also
induced this nonspecific host defense system, which is gener-
ally seen at the early stages of the microbial infections.
To further dissect the mechanisms of IFN-g production dur-
ing the chitin particle treatment, we have modified the spleen
cell culture models established by Tripp et al. (39, 40). Our
data clearly show that phagocytosable-size chitin particles in-
duce significant amounts of IFN-g production and strongly
suggest that the chitin particle-induced IFN-g production ap-
pears to be due to cell-to-cell interactions, especially Mf-to-
NK1.11 cell interaction. CD41 helper T cells or other T cells
(CD81) known as IFN-g producers in various immune re-
TABLE 5. Particle-induced IFN-g production by mouse spleen cells
pretreated with exogenous IFN-ga
Particle Size Dose (mg/ml)
IFN-g (U/ml)
C57BL/6 SCID
Saline ,5 ,5
Chitin 1–10 mm 0.1 102* 116*
Chitosan 1–10 mm 0.1 45* 53*
Chitin 50–100 mm 0.1 9 12
Chitosan 50–100 mm 0.1 6 8
Chitin Oligosaccharide 0.1 ,5 ,5
Chitosan Oligosaccharide 0.1 ,5 ,5
HK C. parvum 0.1 142* 163*
Latex beads 1.1 mm 0.1 84* 88*
47.8 mm 0.1 ,5 ,5
a Spleen cells isolated from C57BL/6 mice and SCID mice were suspended in
RPMI 1640 plus 10% FBS (4 3 106 cells/ml) and incubated with mouse IFN-g
at 100 U/ml for 12 h. Following washing, cells were further incubated with the
particles indicated. After another 24 h of incubation, the culture supernatants
were filtered with a 0.22-mm-diameter filter, and IFN-g levels in the filtrates were
measured by ELISA. These procedures except for the IFN-g pretreatment were
comparable to those for Table 3. Results are expressed as means (n 5 3). p, P ,
0.05 compared with the control (saline) group.
TABLE 6. Modulation of chitin particle-induced IFN-g production
in C57BL/6 spleen cellsa
Treatment Dose
IFN-g (U/ml)
No chitin
particle
Chitin
particle
Saline ,5 88
IL-4 5 ng/ml ,5 7**
IL-10 5 ng/ml ,5 15**
TGF-b1 5 ng/ml ,5 18**
PGE2 1 mM ,5 25**
24-h culture supernatants of
spleen cells stimulated with:
Chitin (1–10 mm) 50% 88* 160**
Chitosan (1–10 mm) 50% ,5 83
Chitin (50–100 mm) 50% ,5 91
Chitosan (50–100 mm) 50% ,5 81
Chitin (Oligo) 50% ,5 87
Chitosan (Oligo) 50% ,5 92
HK C. parvum 50% 103* 166**
Latex beads (1.1 mm) 50% ,5 93
Latex beads (40 mm) 50% ,5 88
a Spleen cells isolated from C57BL/6 mice were suspended in RPMI 1640 plus
10% FBS (4 3 106 cells/ml) and incubated with selected cytokines (IL-4, IL-10,
and TGF-b1) all at 5 ng/ml and PGE2 at 1 mM. In some experiments, spleen cell
suspensions were mixed with an equal volume of the culture supernatant of
particle-stimulated spleen cells (C57BL/6) prepared as for Table 3 (50% dose).
These exogenous mediator-treated spleen cell suspensions were incubated in the
presence or absence of chitin particles (1 to 10 mm) at 0.1 mg/ml. After 24 h of
incubation, the culture supernatants were filtered through a 0.22-mm-diameter
filter, and IFN-g levels in the filtrates were measured by ELISA. Results are
expressed as means (n5 3). p, P, 0.05 compared with control (saline) treatment
in the no-chitin particle treatment groups; pp, P , 0.05 compared with control
(saline) treatment in the chitin particle treatment groups.
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sponses are not involved. Since other bacterial particles such as
HK C. parvum, but not 1.1-mm latex beads, also induced com-
parable levels of IFN-g, these responses might be common
with microbial particulate components (30, 44). Taken to-
gether, the capacities of particles to prime alveolar Mf in vivo
closely parallel the responses of our in vitro cell system.
Recent publications suggest that various steps of CMI re-
sponses (measured by IFN-g production and microbicidal Mf
formation) are regulated by a variety of cells and their inflam-
matory mediators (31), including IL-4 (16, 29, 42), IL-10 (16,
29), TGF-b1 (43), and PGE2 (4). We confirmed here that the
chitin particle-induced IFN-g production in vitro is signifi-
cantly inhibited when costimulated with IL-4, IL-10, TGF-b1,
or PGE2. One could speculate, therefore, that low levels of
IFN-g production by the particles and oligosaccharides other
than the phagocytosable-size chitin particles indicated in Table
3 are due to the production of some negative mediators. How-
ever, our results (Table 6) suggest that there are no such
inhibitory activities produced by these particles. It is more
likely that the particle priming of alveolar Mf is dependent on
the production of interdependent factors up-regulating IFN-g
production, such as IL-12 (17, 32, 40), TNF-a (40), and an
18-kDa IFN-g-inducing factor (IGIF) (27). Our results clearly
demonstrated obligatory roles of IL-12 and TNF-a in this
mechanism. In this regard, it has been reported that TNF-a
alone does not induce IFN-g production but enhances IL-12-
induced IFN-g production (40). The contribution of IGIF,
however, remains to be elucidated.
Consistent with earlier observations (5, 20, 23), in vitro,
exogenous IFN-g can prime normal mouse alveolar Mf which
release massive amounts of SOD-sensitive reactive oxygen in-
termediates. In addition to direct Mf activation by IFN-g, our
present study made a surprising discovery that if C57BL/6 mice
are preconditioned with a small dose of IFN-g, a higher level
of priming is induced by not only phagocytosable chitin parti-
cles but also phagocytosable chitosan and even latex beads.
Furthermore, the in vitro study using spleen cell cultures pre-
conditioned with IFN-g provides an up-regulation of IFN-g
production by these phagocytosable particles, suggesting in-
creases in endogenous IFN-g (nonspecific CMI) in vivo by the
particles. However, nonphagocytosable chitin/chitosan/latex
particles or soluble oligosaccharides of chitin and chitosan fail
to induce significant IFN-g production in these cultures.
Phagocytosis of particulates, probably by a postmembrane
event such as interiorization, appears to be important for the
up-regulation of nonspecific CMI.
Because the chitin particles do not induce detectable levels
of IL-4 in the spleen cell cultures, the inhibition of Th2-derived
cytokine production, unlike in Scott’s Leishmania infectious
models (31), may not be major mechanisms for the effects of
exogenous IFN-g treatment. We speculate that the formation
of Mf-derived immunoregulatory mediators such as IL-12,
IGIF, and TNF-a, which up-regulate CMI (IFN-g production),
is enhanced transcriptionally and translationally when Mf are
exposed to IFN-g and elicited by phagocytosis (36, 37). Al-
though the exact mechanisms remain to be elucidated, circum-
stantial evidence for the phagocytosis-mediated elicitation of
inflammatory mediators has been reported in various Mf ac-
tivation studies (1, 10, 35).
Finally, this observation provides many new avenues of study
that could lead to new methodologies for the up-regulation of
nonspecific CMI that might have important clinical utility. It is
a particularly intriguing idea that IFN-g might have an auto-
crine-like effect on Mf and make them more responsive to
particle priming.
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